Level Biotechnology (ROCO:3118) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:3118 Level Biotechnology Inc ROCO:3118
76 GF Score
Price NT$31.75
GF Value NT$35.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Level Biotechnology Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

ROCO:3118
76GF Score
Level Biotechnology Inc ROCO:3118
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Level Biotechnology (ROCO:3118) Overvalued in 2026?

Based on GuruFocus' analysis, Level Biotechnology stock appears to be undervalued. The current stock price of NT$31.75 is trading 10.7% below its estimated GF Value™ of NT$35.57. GuruFocus considers Level Biotechnology to be Modestly Undervalued.

Key valuation signals for ROCO:3118:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: NT$35.57 vs. price of NT$31.75 (10.7% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the ROCO:3118 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Level Biotechnology Business Description

Address No. 80, Lane 169, Kangning Street, Xizhi District, New Taipei City, TWN, 221
Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services. The company has three reportable segments: Department A and B, Department C, and Department D. Department A and Department B sell the cell culture consumables and the antibody reagents, Department C sells the instruments and equipment, and Department D provides CRO services. The majority of revenue is derived from the Department A and B.
76GF Score

Get the complete analysis for ROCO:3118

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.75
Price
NT$35.57
GF Value